AMIX

$0.00

(

0.00%

)
Quote details

stock

Autonomix Medical, Inc. Common Stock

NASDAQ | AMIX

0.73

USD

(

0.00%

)

At Close (As of Jan 1, 1970)

$5.23M

Market Cap

-

P/E Ratio

-4.51

EPS

$4.58

52 Week High

$0.69

52 Week Low

HEALTHCARE

Sector

AMIX Chart

Recent Chart
Price Action

AMIX Technicals

Tags:

AMIX Earnings

Yearly Income Statement (As of Mar 31, 2025)

Field Value (USD)
Gross Profit -$183K
Total Revenue $0
Cost Of Revenue $183K
Costof Goods And Services Sold $183K
Operating Income -$12M
Selling General And Administrative $6.9M
Research And Development $4.7M
Operating Expenses $12M
Investment Income Net -
Net Interest Income $178K
Interest Income $354K
Interest Expense $176K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $183K
Income Before Tax -$11M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$11M
Comprehensive Income Net Of Tax -
Ebit -$11M
Ebitda -$11M
Net Income -$11M

Revenue & Profitability

Earnings Performance

AMIX Financials

yearly Balance Sheet (As of Mar 31, 2025)

Field Value (USD)
Total Assets $9.8M
Total Current Assets $9.6M
Cash And Cash Equivalents At Carrying Value $9.1M
Cash And Short Term Investments $9.1M
Inventory -
Current Net Receivables -
Total Non Current Assets $197K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $473K
Other Non Current Assets -
Total Liabilities $1.7M
Total Current Liabilities $1.7M
Current Accounts Payable $676K
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $1M
Other Non Current Liabilities -
Total Shareholder Equity $8.1M
Treasury Stock -
Retained Earnings -$50M
Common Stock $2K
Common Stock Shares Outstanding $1.8M

yearly Cash Flow (As of Mar 31, 2025)

Field Value (USD)
Operating Cashflow -$8.3M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $183K
Capital Expenditures $14K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$14K
Cashflow From Financing $8.8M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$11M

yearly Income Statement (As of Mar 31, 2025)

Field Value (USD)
Gross Profit -$183K
Total Revenue $0
Cost Of Revenue $183K
Costof Goods And Services Sold $183K
Operating Income -$12M
Selling General And Administrative $6.9M
Research And Development $4.7M
Operating Expenses $12M
Investment Income Net -
Net Interest Income $178K
Interest Income $354K
Interest Expense $176K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $183K
Income Before Tax -$11M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$11M
Comprehensive Income Net Of Tax -
Ebit -$11M
Ebitda -$11M
Net Income -$11M

AMIX Profile

Autonomix Medical, Inc. Common Stock Profile

Sector: HEALTHCARE

Industry: MEDICAL DEVICES

Autonomix Medical, Inc. is an innovative medical device company headquartered in The Woodlands, Texas, dedicated to advancing treatments for peripheral nervous system disorders. As a development-stage entity, it focuses on the research and commercialization of proprietary neuromodulation technologies designed to improve patient outcomes in neurology and pain management. With a strong commitment to R&D and a pipeline of cutting-edge solutions, Autonomix aims to position itself as a leader in medical advancements that address critical healthcare challenges.

LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
YCBD
+91.75%
$1.21
OCG
-75.85%
$0.22
NVDA
-3.26%
$175.02
CGC
+51.33%
$1.71
YGMZ
-61.42%
$0.02
WOK
-35.71%
$0.10
PLUG
-1.69%
$2.32
ASST
-6.35%
$0.86
RIVN
+12.11%
$18.42
TSLA
+2.30%
$457.20
INTC
-4.30%
$37.81
ONDS
-1.82%
$8.85
TLRY
+43.90%
$12.13
AVGO
-12.32%
$356.27
ATPC
-25.11%
$0.13
KIND
+9.48%
$2.77
IQ
-4.41%
$1.95
AXDX
-61.36%
$0.03
TNYA
-37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN
+19.53%
$0.94
KAVL
-35.55%
$0.12
ORCL
-4.60%
$189.69
SOFI
+0.77%
$27.28
TE
-8.94%
$5.34
VIVK
-1.75%
$0.07
ADAP
-15.14%
$0.05
ZDGE
+18.51%
$2.88
F
+0.88%
$13.75
PLTD
+2.29%
$6.46
AAL
0.00%
$14.96
HPE
-2.68%
$23.88
KVUE
-0.02%
$17.31
SOND
-23.45%
$0.12
MARA
-2.70%
$11.52
PLTR
-2.11%
$183.57
VALE
-4.43%
$12.70
BAC
+1.11%
$55.17
RMBL
+60.50%
$3.21
RR
-11.85%
$4.12
BMNR
-8.59%
$35.08
LNW
-3.71%
$86.22
WULF
-6.66%
$14.77
ADD
-25.47%
$0.05
BMNU
-18.10%
$8.36
SNAP
-4.38%
$7.30
CLSK
-5.33%
$14.03
DNN
-5.06%
$2.62
APLT
-45.91%
$0.11
ACHR
-2.27%
$8.36
IREN
-8.67%
$40.13
SRM
+53.27%
$10.30
PFE
-0.01%
$25.79
BYND
-5.93%
$1.11
IRBT
-14.60%
$4.27
GOOGL
-1.00%
$309.29
RZLT
+28.57%
$1.80
NIO
-2.04%
$5.02
CIFR
-9.69%
$17.05
NFLX
+1.72%
$95.71
ASBP
-5.64%
$0.09
AMD
-4.89%
$210.59
RKLB
-3.05%
$61.59
GRAB
-0.57%
$5.15
BBD
+1.46%
$3.46
CRWV
-8.43%
$80.00
BITF
-4.59%
$2.80
MTSR
-0.35%
$70.50
AMZN
-1.81%
$226.09
FI
+2.38%
$68.16
ABEV
+1.80%
$2.54
WBD
+1.33%
$29.88
HOOD
-2.39%
$120.42
JBLU
+1.02%
$4.94
AAPL
-0.15%
$277.59
HL
-2.76%
$18.81
CHR
0.00%
$0.04
QBTS
-2.99%
$27.14
APLD
-9.42%
$27.86
CAN
-8.01%
$0.85
SOUN
-2.82%
$11.69
BTG
-1.07%
$4.62
AFMD
-34.94%
$0.18
T
+0.89%
$24.51
AG
-5.37%
$15.90
IVP
-9.22%
$0.04
BTBT
-8.22%
$2.25
NOK
-1.49%
$6.26
SMR
-10.50%
$18.99
EOSE
-9.73%
$14.84
TWOH
0.00%
$0.00
CDE
-1.63%
$17.19
KPLT
+17.96%
$7.32
GOOG
-1.01%
$310.52
LUV
+1.08%
$41.18
GRYP
-10.38%
$1.38
TSM
-4.16%
$292.14
BMY
+2.40%
$52.43
LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
YCBD
+91.75%
$1.21
OCG
-75.85%
$0.22
NVDA
-3.26%
$175.02
CGC
+51.33%
$1.71
YGMZ
-61.42%
$0.02
WOK
-35.71%
$0.10
PLUG
-1.69%
$2.32
ASST
-6.35%
$0.86
RIVN
+12.11%
$18.42
TSLA
+2.30%
$457.20
INTC
-4.30%
$37.81
ONDS
-1.82%
$8.85
TLRY
+43.90%
$12.13
AVGO
-12.32%
$356.27
ATPC
-25.11%
$0.13
KIND
+9.48%
$2.77
IQ
-4.41%
$1.95
AXDX
-61.36%
$0.03
TNYA
-37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN
+19.53%
$0.94
KAVL
-35.55%
$0.12
ORCL
-4.60%
$189.69
SOFI
+0.77%
$27.28
TE
-8.94%
$5.34
VIVK
-1.75%
$0.07
ADAP
-15.14%
$0.05
ZDGE
+18.51%
$2.88
F
+0.88%
$13.75
PLTD
+2.29%
$6.46
AAL
0.00%
$14.96
HPE
-2.68%
$23.88
KVUE
-0.02%
$17.31
SOND
-23.45%
$0.12
MARA
-2.70%
$11.52
PLTR
-2.11%
$183.57
VALE
-4.43%
$12.70
BAC
+1.11%
$55.17
RMBL
+60.50%
$3.21
RR
-11.85%
$4.12
BMNR
-8.59%
$35.08
LNW
-3.71%
$86.22
WULF
-6.66%
$14.77
ADD
-25.47%
$0.05
BMNU
-18.10%
$8.36
SNAP
-4.38%
$7.30
CLSK
-5.33%
$14.03
DNN
-5.06%
$2.62
APLT
-45.91%
$0.11
ACHR
-2.27%
$8.36
IREN
-8.67%
$40.13
SRM
+53.27%
$10.30
PFE
-0.01%
$25.79
BYND
-5.93%
$1.11
IRBT
-14.60%
$4.27
GOOGL
-1.00%
$309.29
RZLT
+28.57%
$1.80
NIO
-2.04%
$5.02
CIFR
-9.69%
$17.05
NFLX
+1.72%
$95.71
ASBP
-5.64%
$0.09
AMD
-4.89%
$210.59
RKLB
-3.05%
$61.59
GRAB
-0.57%
$5.15
BBD
+1.46%
$3.46
CRWV
-8.43%
$80.00
BITF
-4.59%
$2.80
MTSR
-0.35%
$70.50
AMZN
-1.81%
$226.09
FI
+2.38%
$68.16
ABEV
+1.80%
$2.54
WBD
+1.33%
$29.88
HOOD
-2.39%
$120.42
JBLU
+1.02%
$4.94
AAPL
-0.15%
$277.59
HL
-2.76%
$18.81
CHR
0.00%
$0.04
QBTS
-2.99%
$27.14
APLD
-9.42%
$27.86
CAN
-8.01%
$0.85
SOUN
-2.82%
$11.69
BTG
-1.07%
$4.62
AFMD
-34.94%
$0.18
T
+0.89%
$24.51
AG
-5.37%
$15.90
IVP
-9.22%
$0.04
BTBT
-8.22%
$2.25
NOK
-1.49%
$6.26
SMR
-10.50%
$18.99
EOSE
-9.73%
$14.84
TWOH
0.00%
$0.00
CDE
-1.63%
$17.19
KPLT
+17.96%
$7.32
GOOG
-1.01%
$310.52
LUV
+1.08%
$41.18
GRYP
-10.38%
$1.38
TSM
-4.16%
$292.14
BMY
+2.40%
$52.43

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.